Market Indices
Sector Heatmap
SPRY — ARS Pharmaceuticals, Inc. Common Stock
NasdaqARS Pharmaceuticals, Inc. Common Stock
- O
- 4.35
- H
- 4.64
- L
- 4.21
- V
- 1.58M
SPRY — Latest News & Headlines
20 StoriesLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY PR Newswire
A stock option with a $4.12 exercise price goes to ARS Pharmaceuticals (SPRY) CEO Donn Casale. - Stock Titan
A stock option with a $4.12 exercise price goes to ARS Pharmaceuticals (SPRY) CEO Donn Casale. Stock Titan
ARS Pharmaceuticals (SPRY) Institutional Ownership 2026 $SPRY - MarketBeat
ARS Pharmaceuticals (SPRY) Institutional Ownership 2026 $SPRY MarketBeat
Bumetanide Nasal Spray Targets Heart Failure Edema Before IV - AJMC
Bumetanide Nasal Spray Targets Heart Failure Edema Before IV AJMC
SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 - Morningstar
SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Morningstar
SPRY Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
SPRY Shareholder Alert: Investors With Losses May Seek to GlobeNewswire
Bears QB Caleb Williams looking ‘spry,’ but still not practicing - The New York Times
Bears QB Caleb Williams looking ‘spry,’ but still not practicing The New York Times
Eric Karas proposes selling 100,000 ARS Pharmaceuticals (SPRY) shares after a $69.8K September sale. - Stock Titan
Eric Karas proposes selling 100,000 ARS Pharmaceuticals (SPRY) shares after a $69.8K September sale. Stock Titan
WDC, STX, SNDK, INTC, AMD: Chip Stocks Rally After Micron's Stellar Q3 Earnings - Stocktwits
WDC, STX, SNDK, INTC, AMD: Chip Stocks Rally After Micron's Stellar Q3 Earnings Stocktwits
Nasal Spray Use May Improve CPAP Mask Tolerance, Survey Finds - Sleep Review
Nasal Spray Use May Improve CPAP Mask Tolerance, Survey Finds Sleep Review
15-year-old arrested after pepper-spraying students at SLO County school, police say - San Luis Obispo Tribune
15-year-old arrested after pepper-spraying students at SLO County school, police say San Luis Obispo Tribune
SoCal heat wave accelerates mosquito breeding, prompts emergency spraying amid West Nile virus concerns - ABC7 Los Angeles
SoCal heat wave accelerates mosquito breeding, prompts emergency spraying amid West Nile virus concerns ABC7 Los Angeles
Kaplan Fox Reminds Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to a Securities Class Action Deadline - Contact the Firm Before October 5, 2026 - Barchart.com
Kaplan Fox Reminds Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to a Securities Class Action Deadline - Contact the Firm Before October 5, 2026 Barchart.com
Hillsborough approves more helicopters, product spray to fight Dengue Fever - WFLA
Hillsborough approves more helicopters, product spray to fight Dengue Fever WFLA
Officer Eric Karas proposes selling 100,000 shares of ARS Pharmaceuticals (SPRY). - Stock Titan
Officer Eric Karas proposes selling 100,000 shares of ARS Pharmaceuticals (SPRY). Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY PR Newswire
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law Business Wire
ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit - PR Newswire
ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Phar - GuruFocus
SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Phar GuruFocus
Bio-Based Spray Oils Market Size, Share, Trends 2036 - Future Market Insights
Bio-Based Spray Oils Market Size, Share, Trends 2036 Future Market Insights